Organization
Iambic Therapeutics
1 clinical trial
1 abstract
Clinical trial
A Phase 1/1b Study of IAM1363 in Patients With Advanced Cancers Harboring HER2 AlterationsStatus: Recruiting, Estimated PCD: 2028-04-01
Abstract
Therapy preferences of patients with cancer.Org: University of Iowa Hospitals & Clinics, Iowa City VA Medical Center, Iambic Therapeutics, University of Nebraska Medical Center, Omaha NE,